TiumBio Co., Ltd. (KOSDAQ:321550)
South Korea · Delayed Price · Currency is KRW 3,590.00
-55.00 (-1.51%)
At close: Nov 5, 2026
TiumBio Market Cap
TiumBio has a market cap or net worth of 107.84 billion as of November 5, 2026. It is the 26,503rd most valuable company in the world and the 1,171st biggest in South Korea. Its market cap has decreased by 52.48% in one year.
Market Cap
107.84B
Enterprise Value
114.93B
Revenue
15.00B
Global Rank
Country Rank
#1,171 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 22, 2019, TiumBio's market cap has decreased from 311.90B to 107.84B, a decrease of -65.43%. That is a compound annual growth rate of -14.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 107.84B | -36.78% |
| Dec 30, 2025 | 170.58B | 51.78% |
| Dec 30, 2024 | 112.39B | -53.28% |
| Dec 28, 2023 | 240.56B | -20.51% |
| Dec 29, 2022 | 302.63B | -34.44% |
| Dec 30, 2021 | 461.60B | -7.09% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 150.86B |
| ISU Abxis | 136.60B |
| Bio Solution | 130.31B |
| Kanaph Therapeutics | 126.62B |
| Y-Biologics | 125.39B |
| Ensol Biosciences | 124.93B |
| AriBioLab | 111.08B |
| Cell Biotech | 101.91B |